Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equipment, Net

Equipment, Net

9 Months Ended

Sep. 30, 2012

6. Equipment, Net



	September 30,		December 31,
	2012		2011

Furniture and fixtures	$	34,200	$	34,200
Office equipment		81,074		81,074
Lab and computer equipment		430,261		430,261
Leasehold improvements		119,841		119,841

Total fixed assets		665,376		665,376
Less: Accumulated depreciation		(602,997)		(570,834)

Net carrying amount	$	62,379	$	94,542

Depreciation expense was $10,721 and $10,127 for the three months ended September 30, 2012 and 2011, respectively, and $32,163, and $34,904 for the nine months ended September 30, 2012 and 2011, respectively.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details